CLIA Quality Control Final Rule Will Offer Added Flexibility For Lab Directors
This article was originally published in The Gray Sheet
Executive Summary
The Centers for Medicare & Medicaid Services will publish its final Clinical Laboratory Improvements Amendments quality control regulation in November, according to CMS Division of Laboratory Services Director Judith Yost
You may also be interested in...
FDA Review Of CLIA Lab Test QC Instructions Not Needed – CMS Quality Rule
Manufacturer-provided quality control instructions for clinical lab assays will not be subject to FDA review, the Centers for Medicare & Medicaid Services declares in its Jan. 24 final rule on CLIA quality systems
FDA Review Of CLIA Lab Test QC Instructions Not Needed – CMS Quality Rule
Manufacturer-provided quality control instructions for clinical lab assays will not be subject to FDA review, the Centers for Medicare & Medicaid Services declares in its Jan. 24 final rule on CLIA quality systems
CLIA Expanded Lab Survey To Address Manufacturer Instructions
The Centers for Medicare & Medicaid Services will follow up its expanded pilot survey of CLIA labs by initiating nationwide site visits to 2% of waived facilities beginning in March